InnoCan Pharma's market cap is currently $61.69M. The company's EPS TTM is C$-0.013; its P/E ratio is ―; InnoCan Pharma is scheduled to report earnings on March 27, 2025, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 13.66M	$ 2.56M	$ 196.00K	$ 8.00K	$ 0.00
Gross Profit	$ 11.98M	$ 2.11M	$ 121.00K	$ 3.00K	$ 0.00
Operating Income	$ 3.80M	$ -6.27M	$ -7.48M	$ -4.72M	$ -3.00M
EBITDA	$ -3.77M	$ -3.85M	$ -10.04M	$ -9.90M	$ -2.98M
Net Income	$ -4.70M	$ -3.89M	$ -10.06M	$ -15.18M	$ -3.67M
Balance Sheet
Cash & Short-Term Investments	$ 3.88M	$ 4.95M	$ 11.05M	$ 2.34M	$ 1.97M
Total Assets	$ 6.94M	$ 6.98M	$ 12.57M	$ 4.33M	$ 2.58M
Total Debt	$ 33.00K	$ 34.00K	$ 1.00K	$ 38.00K	$ 72.00K
Net Debt	$ -3.85M	$ -4.91M	$ -11.05M	$ -2.30M	$ -1.90M
Total Liabilities	$ 2.55M	$ 751.00K	$ 3.56M	$ 7.94M	$ 1.17M
Stockholders' Equity	$ 4.10M	$ 6.39M	$ 9.05M	$ -3.61M	$ 1.41M
Cash Flow
Free Cash Flow	$ -3.95M	$ -6.09M	$ -6.67M	$ -3.69M	$ -2.72M
Operating Cash Flow	$ -3.90M	$ -6.07M	$ -6.63M	$ -3.69M	$ -2.71M
Investing Cash Flow	$ -84.00K	$ -31.00K	$ -48.00K	$ 0.00	$ -9.00K
Financing Cash Flow	$ 2.92M	$ 125.00K	$ 15.30M	$ 4.02M	$ 4.45M

Currency in USD

InnoCan Pharma Earnings and Revenue History

Income Statement >

InnoCan Pharma Debt to Assets

Balance Sheet >

InnoCan Pharma Cash Flow

Cash Flow >

InnoCan Pharma Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing